Enhancing Recovery in Autologous Stem Cell Transplantation: The Impact of Filgrastim Prophylaxis in a Risk-Adapted Protocol

Puntos clave

• Recovery rates improved significantly with filgrastim prophylaxis, indicating its effectiveness in treatment.
• A notable increase in hematopoietic recovery was observed, enhancing patient outcomes during recovery.
• The analysis followed a risk-adapted protocol to tailor treatment based on patient-specific needs.
• Findings imply that filgrastim may optimize recovery timelines, but further validation in broader studies is necessary.